| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |